This site may contain forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical fact, including statements regarding our strategy, future operations, future financial position, future revenues, projected costs, prospects, plans and objectives of management, are forward-looking statements. The words "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "target," "potential," "will," "would," "could," "should," "continue," and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words.

The forward-looking statements on this site include, among other things, statements about: the timing and conduct of our clinical trials of lefamulin, including statements regarding the timing of initiation and completion of the trials, the period during which the results of the trials will become available and the expected design of planned trials; the timing of and our ability to submit applications for, obtain and maintain marketing approval of lefamulin; the potential receipt of revenues from future sales of lefamulin; our plans to pursue development of lefamulin for additional indications other than CABP; our plans to pursue research and development of other product candidates; our ability to establish and maintain arrangements for manufacture of our product candidates; our sales, marketing and distribution capabilities and strategy; our ability to successfully commercialize lefamulin and our other product candidates; the potential advantages of lefamulin and our other product candidates; our estimates regarding the market opportunities for lefamulin and our other product candidates; the rate and degree of market acceptance and clinical benefit of lefamulin and our other product candidates; our ability to establish and maintain collaborations; our ability to acquire or in-license additional products, product candidates and technologies; our anticipated PFIC status; our future intellectual property position; our estimates regarding future expenses, capital requirements and needs for additional financing; our ability to effectively manage our anticipated growth; our ability to attract and retain qualified employees and key personnel; and other risks and uncertainties, including those described in our filings with the Securities and Exchange Commission.

We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Actual results or event could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements we make. You should read this site with the understanding that our actual future results may be materially different from what we expect.

In addition, any forward-looking statements represent our views only as of the date such statements are made and should not be relied upon as representing our views as of any subsequent date. While we may elect to update these forward-looking statements in the future, we do not assume any obligation to do so. Therefore, you should not rely on these forward-looking